Background: On May 29, 2007 AstraZeneca, the maker of Prilosec (omeprazole) and Nexium (esomeprazole), sent FDA data from two long-term studies in patients with severe gastroesophageal reflux disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback